Hamostaseologie 2021; 41(S 01): S12
DOI: 10.1055/s-0041-1728101
Oral Communication
Critical Care, Surgery & Transfusion medicine

Assessment of the anticoagulant effect of direct oral anticoagulants (DOACs) in patients needing immediate management during emergency procedures

M Caspers
1   University of Witten/Herdecke, Institute for Research in operative Medicine, Cologne
,
S Roeschl
2   Department of Cardiology, Cologne-Merheim Medical Center (CMMC), Cologne
,
J Holle
3   Department of Neurology, Cologne-Merheim Medical Center (CMMC), Cologne
,
H Bendella
4   Department of Neurosurgery, Cologne-Merheim Medical Center (CMMC), Cologne
› Author Affiliations
 

Objective Assessment of the anticoagulant effect of direct oral anticoagulants (DOACs) still is a challenge for various medical disciplines, especially in patients needing immediate care in a medical emergency. Aside from severe bleeding and thrombotic events, evaluation of the coagulation status is important for urgent indication of fracture care or administration of a specific antidot. An assay that screens for the absence of a DOAC might help accelerate treatment in these situations. The goal of this study is to evaluate the use of a qualitative POC Method (DOAC Dipstick, DOASENSE®) in an emergency setting.

Material and Methods Between 11/2019 and 04/2020 the POC method was available for all clinicians in a level I emergency department. The POC testing was indicated by the physician on duty followed by a standardized questionnaire on basic patients’ parameters, indication for the qualitative testing and drawn conclusions based on the tests´ results. Intraindividual reliability blinded to the clinical user (visual testing vs. semiquantitative reader) as well as the interindividual reliability compared with standard anti-factor-Xa (antiXa)- or direct-thrombin-inhibitor (DTI)-tests were investigated.

Results In total, 82 patients were included (30 % Neurology, 50 % Trauma, 10 % Neurosurgery, 10 % Internal Medicine) 28 patients being anticoagulated with antiXa inhibitor and 7 patients with dabigatran. Test results of POC testing could be confirmed using standard anti-factor-Xa (antiXa)- or direct-thrombin-inhibitor (DTI)-tests in all cases. In most cases the POC test was used to identify unknown DOAC status in patients who could not be interviewed concerning their medication. 12 patients received a lysis therapy after exclusion of DOAC anticoagulation, 2 patients were treated with a specific antidot after a major bleeding event. In 6 patients the POC test demonstrated a positive result in patients that stopped using the oral medication several days ago.

Conclusion In an emergency with an immediate consequence under time pressure, the POC test might provide a significant time advantage compared to standard laboratory testing. Due to the cumulative effect within the patients´ urine the test can only be used for the qualitative verification and does not provide any information concerning the actual anticoagulative effect.



Publication History

Article published online:
18 June 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany